4 reports of 'non-serious adverse events' in over 2000 doses of Nuvaxovid Covid-19 vaccine administered: HSA - TODAY

SINGAPORE — As of May 31, there have been four reports of "non-serious adverse events" in the two weeks following the roll-out of the Nuvaxovid Covid-19 vaccine in Singapore, the Health Sciences Authority (HSA) said on Monday (June 27).

SINGAPORE As of May 31, there have been four reports of "non-serious adverse events" in the two weeks following the roll-out of the Nuvaxovid Covid-19 vaccine in Singapore, the Health Sciences Author… [+3109 chars]

full article...